Integrating Diphenyl Diselenide and Its MeHg+ Detoxificant Mechanism on a Conceptual DFT Framework

Methylmercury is an important environmental contaminant and its toxicity in vertebrates is associated with its interaction with selenium (e.g., selenol groups of selenoproteins or HSe- the pivotal metabolite for selenium incorporation into selenoproteins). In a previous study, we demonstrated that diphenyl diselenide (PhSe)2 decreased the deposition of Hg in mice treated with MeHg+. We hypothesized that (PhSe)2 could be reduced metabolically to its selenol intermediate phenylselenol (PhSeH), which reacted with MeHg+ to form PhSeHgMe. To further support our hypothesis, in this work, we investigate the electronic chemical reactivity descriptors at ZORA-OPBE-D3(BJ)/ level of theory using the Fukui functions and the Dual descriptors. The results indicate that (PhSe)2 and diphenyl disulfide (PhS)2 (f+ > f- ) act as poor nucleophiles towards MeHg+ and thus cannot be the detoxificant agent. As further proof, the reaction between diphenyl diselenide and MeHgCl was followed via UV-vis spectrophotometry and the spectra of the relevant species were computed using time-dependent density functional theory (TD-DFT) (CPCM-ZORA-CAM-B3LYP/ZORA-def2-TZVP). The large aromatic system in (PhSe)2 ensures the delocalization of electrons and directly influences the HOMO-LUMO gap (HLG) (3.34 eV) < HLG of PhSeH (3.99 eV). A similar trend was observed with HLG (2.65 eV) for (PhS)2 and 4.13 eV for PhSH. This selenol intermediate is the active reactant, experimentally generated from the reduction of (PhSe)2 by NaBH4, which in presence of MeHgCl forms methylmercury phenylselenide complex (PhSeHgMe), i.e. a non-toxic metabolite of methylmercury formed after administration of (PhSe)2 to mice

<i>In silico</i> analysis of the antidepressant fluoxetine and similar drugs as inhibitors of the human protein acid sphingomyelinase: a related SARS-CoV-2 inhibition pathway

Acid Sphingomyelinase (ASM) is a human phosphodiesterase that catalyzes the metabolism of sphingomyelin (SM) to ceramide and phosphocholine. ASM is involved in the plasma membrane cell repair and is associated with the lysosomal inner lipid membrane by nonbonding interactions. The disruption of those interaction would result in ASM release into the lysosomal lumen and consequent degradation of its structure. Furthermore, SARS-CoV-2 infection has been linked with ASM activation and with a ceramide domain formation in the outer leaflet of the plasma membrane that is thought to be crucial for the viral particles recognition by the host cells. In this study, we have explored in silico the behavior of fluoxetine and related drugs as potential inhibitors of ASM. Theoretically, these drugs would be able to overpass lysosomal membrane and reach the interactions that sustain ASM structure, breaking them and inhibiting the ASM. The analyses of docking data indicated that fluoxetine allocated mainly in the N-terminal saposin domain via nonbonding interactions, mostly of hydrophobic nature. Similar results were obtained for venlafaxine, citalopram, atomoxetine, nisoxetine and fluoxetine’s main metabolite norfluoxetine. In conclusion, it was observed that the saposin allocation may be a good indicative of the drugs inhibition mechanism, once this domain is responsible for the binding of ASM to lysosomal membrane and some of those drugs have previously been reported to inhibit the phosphodiesterase by releasing its structure in the lysosomal lumen. Our MD data also provides some insight about natural ligand C18 sphingomyelin conformations on saposin. Communicated by Ramaswamy H. Sarma</p

Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (Mpro) and Papain-like Protease (PLpro)

The SARS-CoV-2 pandemic has prompted global efforts to develop therapeutics. The main protease of SARS-CoV-2 (Mpro) and the papain-like protease (PLpro) are essential for viral replication and are key targets for therapeutic development. In this work, we investigate the mechanisms of SARS-CoV-2 inhibition by diphenyl diselenide (PhSe)2 which is an archetypal model of diselenides and a renowned potential therapeutic agent. The in vitro inhibitory concentration of (PhSe)2 against SARS-CoV-2 in Vero E6 cells falls in the low micromolar range. Molecular dynamics (MD) simulations and density functional theory (DFT) calculations [level of theory: SMD-B3LYP-D3(BJ)/6-311G(d,p), cc-pVTZ] are used to inspect non-covalent inhibition modes of both proteases via pi-stacking and the mechanism of covalent (PhSe)2 + Mpro product formation involving the catalytic residue C145, respectively. The in vitro CC50 (24.61 mu M) and EC50 (2.39 mu M) data indicate that (PhSe)2 is a good inhibitor of the SARS-CoV-2 virus replication in a cell culture model. The in silico findings indicate potential mechanisms of proteases' inhibition by (PhSe)2; in particular, the results of the covalent inhibition here discussed for Mpro, whose thermodynamics is approximatively isoergonic, prompt further investigation in the design of antiviral organodiselenides